Eye injection safety check: could common treatment raise heart risk?
NCT ID NCT07550777
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether repeated eye injections of bevacizumab, a drug used for diabetic eye disease and other conditions, might affect heart health. Researchers will measure certain enzymes in the blood that are linked to heart disease risk. The study includes 180 adults aged 55 and older who have had at least two injections, plus a healthy comparison group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bevacizumab (eye injection)
What this could lead to
If successful, this study could help doctors understand whether repeated bevacizumab eye injections raise the risk of heart problems, leading to safer treatment plans.
What could go wrong
This is an observational study, not a treatment trial. It only measures blood markers, not actual heart events, so it cannot prove cause and effect. Results may not change practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ataturk University Research Hospital, Department of Ophthalmology
RECRUITINGErzurum, Erzurum, 25240, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••